Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Rockwell Medical (RMTI) over the last 14 years, with Sep 2025 value amounting to $6.7 million.

  • Rockwell Medical's Cash from Financing Activities rose 191.57% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 112.45%. This contributed to the annual value of $7.3 million for FY2024, which is 35.21% down from last year.
  • As of Q3 2025, Rockwell Medical's Cash from Financing Activities stood at $6.7 million, which was up 1,137.54% from -$650,000 recorded in Q2 2025.
  • Rockwell Medical's 5-year Cash from Financing Activities high stood at $26.8 million for Q2 2022, and its period low was -$6.0 million during Q4 2022.
  • Its 3-year average for Cash from Financing Activities is $2.2 million, with a median of $178,000 in 2024.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 162,300.00% in 2021, then skyrocketed by 447,150.00% in 2022.
  • Over the past 5 years, Rockwell Medical's Cash from Financing Activities (Quarterly) stood at -$1.6 million in 2021, then slumped by 268.47% to -$6.0 million in 2022, then skyrocketed by 87.60% to -$742,000 in 2023, then spiked by 476.28% to $2.8 million in 2024, then soared by 191.57% to $6.7 million in 2025.
  • Its Cash from Financing Activities was $6.7 million in Q3 2025, compared to -$650,000 in Q2 2025 and -$783,000 in Q1 2025.